Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunome Inc
(NQ:
IMNM
)
13.99
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
13.99
Bid (Size)
11.60 (2)
Ask (Size)
14.85 (8)
Prev. Close
13.99
Today's Range
13.99 - 13.99
52wk Range
6.130 - 30.96
Shares Outstanding
59,968,868
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Immunome Appoints Phil Tsai as Chief Technical Officer
June 27, 2024
From
Immunome, Inc.
Via
Business Wire
Evaluating Immunome: Insights From 4 Financial Analysts
May 31, 2024
Via
Benzinga
Performance
YTD
+27.07%
+27.07%
1 Month
+6.39%
+6.39%
3 Month
-19.51%
-19.51%
6 Month
-0.07%
-0.07%
1 Year
+80.52%
+80.52%
More News
Read More
Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
May 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 21, 2024
Via
Benzinga
Immunome Announces Completion of Purchase of Assets from Atreca
May 20, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
May 17, 2024
From
Immunome, Inc.
Via
Business Wire
IMNM Stock Earnings: Immunome Beats EPS, Misses Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome to Present at 2024 Bank of America Healthcare Conference
May 08, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome Appoints Kinney Horn as Chief Business Officer
May 02, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome Appoints Sandra M. Swain to Board of Directors
April 25, 2024
From
Immunome
Via
Business Wire
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
April 05, 2024
From
Immunome, Inc.
Via
Business Wire
IMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023
March 28, 2024
Via
InvestorPlace
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
March 28, 2024
From
Immunome, Inc.
Via
Business Wire
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
March 28, 2024
Via
Benzinga
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
March 26, 2024
From
Immunome, Inc.
Via
Business Wire
Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
March 26, 2024
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
March 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Immunome to Participate in the Leerink Partners Global Biopharma Conference
March 07, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference
March 01, 2024
From
Immunome, Inc.
Via
Business Wire
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
February 28, 2024
Via
Benzinga
How I Swing Trade Via Strength With Recent Examples
February 25, 2024
Via
Talk Markets
Immunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
February 20, 2024
From
Immunome, Inc.
Via
Business Wire
Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
February 20, 2024
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 16, 2024
From
Immunome, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.